Galectin-3 expression in parathyroid carcinoma: Immunohistochemical study of 26 cases

Human Pathology

Volumn 36, Issue 8, 2005, Pages 908-914

  Bergero, Nicoletta ^a   De Pompa, Roberta ^a   Sacerdote, Carlotta ^a   Gasparri, Guido ^a   Volante, Marco ^a   Bussolati, Gianni ^a   Papotti, Mauro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Galectin 3; Parathyroid carcinoma

Indexed keywords

GALECTIN 3; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INFILTRATION; CANCER INVASION; CANCER RECURRENCE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PARATHYROID CARCINOMA; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ADENOMA; ADULT; AGED; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 23944505256     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.06.020     Document Type: Article

References (26)

1. F. Orlandi, E. Saggiorato, G. Pivano, B. Puligheddu, A. Termine, and S. Cappia Galectin-3 is a presurgical marker of human thyroid carcinoma Cancer Res 58 1998 3015 3020
2. N.L. Perillo, M.E. Marcus, and L.G. Baum Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death J Mol Med 76 1998 402 412
3. A. Bartolazzi, A. Gasbarri, M. Papotti, G. Bussolati, T. Lucante, and A. Khan Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions Lancet 357 2001 1644 1650
4. M. Volante, F. Bozzalla-Cassione, F. Orlandi, and M. Papotti Diagnostic role of galectin-3 in follicular thyroid tumors Virchows Arch 444 2004 309 312
5. L. Martins, S.E. Matsuo, K.N. Ebina, M.A. Kulcsar, C.U. Friguglietti, and E.T. Kimura Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors J Clin Endocrinol Metab 87 2002 4806 4810
6. M. Niedziela, J. Maceluch, and E. Korman Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents J Clin Endocrinol Metab 87 2002 4411 4415
7. M.E. Herrmann, V.A. LiVolsi, T.L. Pasha, S.A. Roberts, E.M. Wojcik, and Z.W. Baloch Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions Arch Pathol Lab Med 126 2002 710 713
8. E. Saggiorato, S. Cappia, P. De Giuli, A. Mussa, G. Pancani, and P. Caraci Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma J Clin Endocrinol Metab 86 2001 5152 5158
9. M. Papotti, M. Volante, E. Saggiorato, D. Deandreis, A. Veltri, and F. Orlandi Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma Eur J Endocrinol 147 2002 515 521
10. R.A. DeLellis Tumors of the parathyroid gland J. Rosai L.H. Sobin Atlas of tumor pathology 3rd series, fascicle 6 1993 Armed Forces Institute of Pathology Washington (DC) 53 63
11. G.L. Clayman, H.E. Gonzalez, A. El-Naggar, and R. Vassilopoulou-Sellin Parathyroid carcinoma: evaluation and interdisciplinary management Cancer 100 2004 900 905
12. R.L. Apel, and S.L. Asa The parathyroid glands V.A. LiVolsi S.L. Asa Endocrine pathology 2002 Churchill Livingstone New York 103 147
13. A. Schantz, and B. Castleman Parathyroid carcinoma: a study of 70 cases Cancer 31 1973 600 605
14. R.A. DeLellis, R.V. Lloyd, P.U. Heitz, and C. Eng Pathology and genetics of tumors of the endoctrine organs P. Kleihues L.H. Sobin World Health Organization classification of tumors 2004 IARC Press Lyon 124 132
15. G.C. Abbona, M. Papotti, G. Gasparri, and G. Bussolati Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining Hum Path 26 1995 135 138
16. L.A. Erickson, L. Jin, P. Wollan, G.B. Thompson, J.A. van Heerden, and R.V. Lloyd Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27 protein Am J Surg Pathol 23 1999 288 295
17. A. Stojadinovic, A. Hoos, A. Nissan, M.E. Dudas, C. Cordon-Cardo, and A.R. Shaha Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis Hum Path 34 2003 54 64
18. F. Cetani, E. Pardi, P. Viacava, G.D. Pollina, G. Fanelli, and A. Picone A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer Clin Endocrinol 60 2004 99 106
19. A. Falchetti, A.E. Bale, A. Amorosi, C. Bordi, P. Cicchi, and S. Bandini Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11 J Clin Endocrinol Metab 76 1993 139 144
20. L.A. Erickson, S.M. Jalal, A. Harwood, B. Shearer, L. Jin, and R.V. Lloyd Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization Am J Surg Pathol 28 2004 578 584
21. M. Kammori, K. Nakamura, T. Ogawa, K. Mafune, Y. Tatutomi, and T. Obara Demonstration of human telomerase reverse transcriptase (hTERT) in human parathyroid tumors by in situ hybridisatin with a new oligonucleotide probe Clin Endocrinol 58 2003 43 48
22. G. Tuccari, G.C. Abbona, G. Giuffrè, M. Papotti, G. Gasparri, and G. Barresi AgNOR quantity as a prognostic tool in hyperplastic and neoplastic parathyroid glands Virchows Arch 437 2000 298 303
23. L.A. Erickson, L. Jin, M. Papotti, and R.V. Lloyd Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases Am J Surg Pathol 26 2002 344 349
24. G. Abbona, M. Papotti, G. Gasparri, and G. Bussolati Recurrence in parathyroid hyperplasias owing to secondary hyperparathyroidism is predicted by morphological patterns and proliferative activity values Endocr Pathol 7 1996 55 61
25. G. Gasparri, M. Camandona, G.C. Abbona, M. Papotti, A. Jeantet, and E. Radice Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies Ann Surg 233 2001 65 69
26. C. Morrison, W. Farrar, J. Kneile, N. Williams, Y. Liu-Stratton, and A. Bakaletz Molecular classification of parathyroid neoplasia by gene expression profiling Am J Pathol 165 2004 565 576